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Complement-mediated cytolyfic and bacteriocidal reactions are thought to require 
the sequential participation and activation of the complement component proteins in 
the order C1, C4, C2, C3, C5, C6, C7, C8, and C9 (1, 2). Many complement-mediated 
inflammatory responses,  however,  require  the  activation of  only  a  portion  of  the 
complement sequence.  Thus,  activation need  only proceed through  C3  and  C5  for 
generation  of  chemotactic  and  anaphylatoxic  factors  (3-7).  It could  therefore  be 
anticipated that animals with a total deficiency of one of the later components in the 
complement sequence might have a defect in serum cytolytic and bacteriocidal func- 
tions,  but remain healthy because of the existance  of intact inflammatory functions. 
This is the case in strains of mice with a genetically  controlled  deficiency of C5 (8, 9) 
and in rabbits with a deficiency of C6 (10, 11). 
We have recently reported development of a strain of guinea pigs with a total 
deficiency of hemolytically active C4,  one of the components which acts early 
in the complement sequence (12). These animals also appear to be healthy and 
display  normal  complement-dependent  inflammatory  responses,  including 
normal  direct  and  reverse passive Arthus  reactions  and  a  normal  exudative 
response to a foreign body (13). These findings suggest that the animals possess 
a  bypass  mechanism  or  alternate  pathway  into  the  complement  sequence, 
which allows them to fix components beyond C4 and  to generate biologically 
active fragments of complement in the  absence of C4.  This paper documents 
in vitro studies designed to demonstrate this postulated bypass mechanism. It 
attempts to further define the nature of the complement defect in these animals 
and  to  determine  whether  these  deficient  animals  have  deficiencies in  other 
components  of  complement.  In  addition,  the  relationship  of  C4-deficient 
guinea pigs to an earlier described complement-deficient guinea pig strain (14) 
has  also  been  investigated. 
MATERIALS AND METHODS 
Purified Complement Proteins and Complement Reagents.--Preparation of isotonic veronal- 
buffered saline containing 0.1% gelatin, 0.00015 ~t calcium, and 0.001 M magnesium (VBS),  1 
1  Abbreviations used in this paper: CFA, complete Freund's  adjuvant;  disodium-EDTA 
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0.065  /z  isotonic  dextrose-veronal-buffered  saline  containing  0.1%  gelatin,  0.00015 
calcium,  and 0.001  ~  magnesium  (DVBS), isotonic veronal-buffered saline containing 0.01 
disodium ethylene-dinitrilotetraacetate and 0.1% gelatin (disodinm-Ei)TA buffer), sources 
of antibody, preparation of washed optimally sensitized sheep erythrocytes (EA), preparation 
of complement-cell intermediates, and methods of complement component titration have all 
been described  (15-17).  Partially purified complement components were either prepared in 
our laboratory or obtained from  Cordis Corp.,  Miami,  Fla.  Pooled  guinea pig serum was 
obtained from Suburban Serum Laboratory,  Silver Spring,  Md.,  and was employed  as the 
serum  complement source for  the preparation of  cellular intermediates  and  in  hemolytic 
analyses. Kinetic studies of the hemolytic activation of C1  were performed as described by 
Borsos et al. (18). 
Materials  Utilized For Immunization and Complement-Fixation  Reactions.--Human serum 
albumin  (HSA)  was  obtained  from  Behringwerke  AG,  Marburg-Lahn,  West  Germany. 
Escherichia coli lipopolysaccharide (endotoxin) strain 012:B8 and Freund's complete  (CFA) 
and incomplete adjuvants were obtained from Difco Laboratories, Detroit, Mich. In studies 
of complement fixation in C4-deficient sera, normal serum was obtained from the same strain 
from which the C4-deficient animals were derived ("NIH multipurpose strain"). C4-deficient 
guinea pigs were mated with NIH multipurpose guinea pigs heterozygous for C4  (12).  The 
serum  of  the  C4-deficient offspring  and  the  heterozygous littermates were  utilized  in the 
comparative studies presented in this report. 
Ability of Zymosan-Absorbed  Guinea Pig Serum to Restore the Hemolytic  Capacity  of C4- 
Deficient Sera.--Powdered  zymosan  (Nutritional Biochemical Corp.,  Cleveland, Ohio)  was 
incubated with pooled guinea pig serum in concentrations of 24, 48, and 72 mg of zymosan/ml 
of guinea pig serum in an attempt to duplicate the conditions described by Hyde (19). After 
2  hr incubation at  37°C  the  sera  were  centrifuged,  the  supernatants were  decanted,  and 
dilutions of 1:1000,  1:10,000, and 1:20,000 were prepared in cold I)VBS. A volume of 0.25 
ml of  each of  the various dilutions of  zymosan-treated guinea pig serum was  added  to  a 
mixture of 0.25 ml of EA containing 1.5 X  l0 s cells/ml of VBS and 0.25 ml of C4-deficient 
serum, diluted 1 : 50 in the same buffer. After incubation at 37°C for 90 min, 2.5 ml of disodium- 
EDTA  buffer was  added  and  the  extent  of  hemolysis determined  spectrophotometrically. 
Controls included EA incubated with either C4-deficient guinea pig serum alone, zymosan- 
treated normal guinea pig serum, or normal guinea pig serum diluted 1:20,000 in VBS. 
Preparation of Guinea Pig and Rabbit Anti-C4.--Guinea pig anti-C4 antisera were prepared 
in C4-deficient guinea pigs by injection of 0.1 ml of an emulsion of pooled  guinea pig serum 
in an equal volume of CFA into each footpad. Animals were bled 2 wk later. 
To investigate the possibility of a C4-1ike molecule in the C4-deflcient sera, an attempt was 
made to produce a guinea pig antiserum to the C4-deficient serum. Strain 13, Hartley strain, 
and normal NIH guinea pigs were injected with 0.1 ml of an emulsion of pooled C4-deficient 
serum in an equal volume of CFA into each footpad. Animals were bled 2 wk later. 
Anti-C4 antiserum was also prepared in New Zealand albino rabbits by immunization with 
HSA complexed with rabbit anfi-HSA and guinea pig C4. The complexes were prepared by 
reacting at equivalence purified HSA with anti-HSA serum (produced in rabbits: by multiple 
intravenous injection of HSA)  for 1 hr at 37°C  in the presence of 0.01 ~  disodium-EDTA 
buffer to prevent fixation of rabbit complement. The precipitate was washed once with cold 
disodium-EDTA buffer, three times with cold saline, and resuspended in 0.25 ml of DVBS. 
It was then incubated with an excess of partially purified C1 for 15 min at 37°C.  C4 was 
buffer,  isotonic veronal-buffered saline  containing 0.01  ~r  disodium  ethylenedinitrilotetra- 
acetate  and  0.1%  gelatin;  DVBS,  0.065  /z  isotonic  dextrose-veronai-buffered saline  con- 
taining 0.1% gelatin, 0.00015  ~ calcium, and 0.001  M magnesium; EA, washed optimally sensi- 
tized sheep erythrocytes; HSA, human serum albumin; VBS, isotonic veronal-buffered saline 
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added to the complex by the addition of whole guinea pig serum diluted  1:10 in disodium- 
EDTA  buffer. During this procedure  C1  is removed from the antigen-antibody complexes 
(16).  The complexes were then thoroughly washed with disodium-EDTA buffer and DVBS, 
dissolved in saline, and emulsified with an equal volume of CFA. A volume of 0.25 ml of the 
emulsion was injected into the footpads and 0.5 ml into the neck of each rabbit. 2 wk later 
the  animals received  a  booster injection of  the complement-cell intermediate EAC4  (16) 
emulsified in incomplete Freund's adjuvant, and 2 wk after the booster injection the animals 
were bled. 
Inhibition of SAC4 by Guinea Pig Anti-C4 Antiserum.~Fhe  ability of guinea pig anti-C4 
to inhibit the activity of the cell-complement intermediate site SAC4 was examined in Tmax 
studies (15) utilizing SAC4 which had been exposed to either guinea pig anti-C4 serum or C4- 
deficient serum (without antibody). 5 ml aliquots of SAC4 were incubated for 30 min at 37°C 
with either 0.1 ml of heat-inactivated anti-C4 serum or 0.1 ml of heat-inactivated C4-deficient 
serum. The cells were washed, resuspended in 60% dextrose buffer to their original concentra- 
tion (1.5  X  l0 s cells/ml),  and reacted with an excess of partially purified  Cla to prepare 
SAC14. Kinetic analysis of the generation of SAC142 from SAC14 by the addition of C2 to 
SAC14 was then performed on each of the samples to determine the number and availability 
of SAC 14. 
Complement Consumption by Immune Complexes and Endotoxin.--Immune  complexes of 
HSA-rabbit anti-HSA were prepared and washed as described above, and the final protein 
concentration determined by Kjeldahl nitrogen analysis. Studies of fixation of C' components 
by  immune complexes were  performed  with pooled  sera  from  normal,  heterozygous,  and 
homozygous C4-deficient guinea pigs. The immune complexes (575 or 57/zg) were incubated 
with 1 ml of freshly obtained, pooled serum. To eliminate dilution of the guinea pig serum, 
samples  were  added  directly  to  washed  antigen-antibody precipitates.  After  mixing,  the 
samples were incubated at 37°C for 1 hr. They were centrifuged for 10 min at 48,000 g at 0°C 
and clear supernatant sera were decanted. These were titrated for C1, C4, C2, and the classical 
C3-9  complex.  In  additional  experiments  immune  complexes  were  prepared  with  rabbit 
antisera which were preheated to 56°C for 20 min and to which disodium-EDTA buffer was 
added to a  final concentration of 0.04 •.  Both the disodium-EDTA buffer and the heating 
exclude the possibility of participation of rabbit C4 in the formation of these complexes. 
The ability of E. coli endotoxin to deplete C4-deficient serum of the late-acting complement 
components was also explored. Dried samples of endotoxin (120 or 30 #g) were incubated with 
1 ml of freshly obtained serum from homozygous C4-deficient, heterozygous, or normal multi- 
purpose guinea pigs. The serum was incubated as described above and component titrations 
performed. 
RESULTS 
Effect of Zymosan-Absorbed  Guinea Pig Serum on  the Hemolytic Capacity of 
C4-Deficient Sera.--Pooled guinea pig serum treated with 76 mg/ml  of zymosan 
and subsequently diluted  1:20,000  restored the hemolytic capacity of  the C4- 
deficient  sera.  This  quantity  of zymosan  reduced  whole  complement  activity 
of the serum by 98.3 %.  Controls consisting of EA with the zymosan-absorbed 
sera  and  EA  with  C4-deficient  serum  showed  no  hemolysis  (Table  I).  Thus, 
there  was  no  evidence  that zymosan  removed  the factor  that  enables  normal 
guinea pig serum  to restore  the hemolytic capacity  of  the C4-deficient serum. 
Properties of Guinea Pig and Rabbit  Anti-C4  Serum.--Guinea  pig  anti-C4 
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analysis in gel (2). It failed to react with rabbit, mouse, rat,  or goat serum, 
but one antiserum gave a weak precipifin line against human serum. The anti- 
C4 serum agglutinated EAC4  and failed to agglutinate EAC1  or EA.  EAC4 
incubated with guinea pig anti-C4 showed no lysis on addition of C2 and the 
late components of complement (Fig. 1). This compares to the normal hemolytic 
curve (Tmax) generated after these cells were incubated with C4-deficient sera 
containing no anti-C4 antibody. Thus, anti-C4 can efficiently block the active, 
cell bound,  C4  site. 
Strain 13, Hartley strain, and normal NIH guinea pigs immunized with C4- 
deficient serum failed to produce detectable antibody by Ouchterlony analysis 
against C4-deficient serum. These animals were immunized in a manner identi- 
cal  to the immunization of C4-deficient guinea pigs with normal guinea pig 
TABLE I 
Ability of Zymosan-Treated Normal Serum to Restore Hemolytic Activity of 
C4-Deficient Serum 
Per cent lysis of optimally sensitized sheep erythrocytes incubated for 90 rain in the presence of 
C4-deficient serum 1  : 50 
Zymosan-treated normal guinea pig serum or normal guinea 
pig serum 1:20,000 
C4-deficient serum 1:50 plus 1:20,000 normal guinea pig 
serum 
C4-deficient serum  1: 50  plus  1: 20,000 zymosan-treated 
normal guinea pig serum 
% 
0.6 
0.3 
93.5 
96.5 
serum, which yielded precipitating antibody against a protein in normal guinea 
pig serum. Thus, the possibility of an altered C4 molecule in the C4-deficient 
serum  is  unlikely. 
Fig.  2 illustrates  that rabbit anti-C4  and guinea pig anti-C4 both show a 
line of precipitation in gel against normal guinea pig serum. These lines fuse 
indicating partial identity. The rabbit anti-C4 and the guinea pig anti-C4 fail 
to show a precipitin line against C4-deficient serum. 
Level of Complement  Components in C4-Deficient Guinea Pigs.--Table II lists 
the mean fiters and range of C1,  C4, C2, and C3-9 complex in normal, hetero- 
zygous C4-deficient, and homozygous C4-deficient guinea pig sera. Serum titers 
of C2 in the C4-deficient animals were consistently about one-half the C2 titers 
of the heterozygous and normal animals. The titer of C2 in the C4-deficient 
guinea pigs, although less than heterozygous or normal NIH multipurpose ani- 
mals,  is in the same range as that obtained utilizing normal pooled Hartley 
strain guinea pig serum. Analysis of C1  titers indicated that the C4-deficient 
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mals studied, C1 was consistently found to be present in very low titers. Three 
animals had titers  of C1 which were roughly in the normal range (Table II). 
In an effort to determine whether a low C1 titer indicated an absolute decrease 
in the C1 level or resulted from abnormal activation of C1 or the presence of a 
C1 inhibitor in these sera, kinetic studies of the activation of C1 were performed. 
As can be seen  in  Fig.  3,  C1  activation in  C4-deficient sera  appeared  to  be 
normal although the quantity of C1 was reduced. The presence of C1 inhibitor 
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FIo. 1. Ability of guinea pig anti-C4 to inhibit the functional activity of the cellular site 
SAC4. 
or impaired activation of C1 seems unlikely. The titers of C3-9 complex were 
normal in  the  C4-deficient animals. 
Complement Consumption in the C4-Defident Sera by Immune Complexes and 
Endotoxin.--Incubation  of immune complexes with normal, heterozygons, and 
homozygous deficient sera led to substantial consumption of both the early and 
late components (C3-9 complex)  of complement (Fig.  4).  The  per  cent  con- 
sumption of components beyond C4 was  significantly reduced in  the  sera  of 
C4-deficient animals. However, C2 and the late components are unequivocally 
consumed. 
The effect of endotoxin on the  consumption profile  of complement compo- 
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(20).  While antigen-antibody  complexes fixed both early and late complement 
components, incubation of normal NIH guinea pig serum with endotoxin led to 
considerable fixation of the late components (C3-9)  with only minimal fixation 
of C1,  C4, and C2  (See Fig. 5). In a  similar manner,  incubation  of C4-deficient 
sera  with  endotoxin  led  to  substantial  fixation  of  the  late  components  with 
[  FIo  2. Ouchterlony  analysis demonstrating absence of C4 protein in C4-deficient guinea 
pig serum. C4D, C4-deficient serum; N1  GPS, normal guinea pig serum;  Rb anti-C4,  rabbit 
anti-C4;  GP anti-C4,  guinea pig anti-C4 prepared in a C4-deficient guinea pig. 
TABLE  II 
Titers of Complement Components in C4-Deficient, Heterozygous Deficient, and Normal 
Guinea Pigs 
Normal 
Heterozygous 
Homozygous 
C1  C4  C2  C3-9 
52,338*  (4) 
39,420-58,8285 
40,734  (4) 
30,303-52,631 
(A) 34,027  G) 
29,411-40,000 
(B)  7,815  (5) 
4,545-12,195 
73,230(4) 
40,000-125,000 
15,713  (4) 
5,556-22,727 
0 (15) 
13,094  (6) 
6,138-18,867 
10,161  (6) 
8,333-13,699 
4,402  (7) 
2,632-7,672 
1,654  (6) 
917-3,300 
753 (4) 
500-1,190 
1,654  (5) 
658-3,225 
* Mean (number of animals). 
:~ Range. 
negligible  consumption  of C1  and  C2.  The degree of fixation  of the late  com- 
ponents  was  roughly  equivalent  for  C4-deficient,  heterozygous,  and  normal 
NIH  guinea  pig  serum. 
DISCUSSION 
Previous studies utilizing an extremely sensitive hemolytic assay have shown 
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pigs  (12). In this study,  an attempt was made to determine whether sera of 
these  animals  possess  a  C4-1ike  molecule without  hemolytic  activity.  The 
ability  of  C4-deficient  animals  to  produce  large  amounts  of  anti-C4  when 
immunized with normal guinea pig serum, suggests that the C4-deficient guinea 
pigs either entirely lack C4 or possess a nonfunctional variant of the molecule 
which differs from the normal C4 molecule by multiple antigenic determinants. 
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FIo. 3. Kinetics of activation of C1 to C1 in the hemolytic system. Sites generated equal 
to --In (1 -- Y) X dilution. 
Since strain 13, Hartley strain,  and normal NIH guinea pigs immunized with 
C4-deficient serum fail to make antibody to any component in the C4-deficient 
serum, the presence of an allotypic variant or an aberrant C4 molecule in the 
serum of the C4-deficient guinea pigs is unlikely. Moreover, antibody to normal 
C4  produced in  an  unrelated  species  (the rabbit)  recognizes nothing in  the 
serum  of  the  C4-deficient guinea  pigs.  The  evidence thus  strongly suggests 
that C4-deficient guinea pigs are entirely lacking in C4. 
Because of their absolute deficiency in this early component in the comple- 
ment sequence,  C4-deficient guinea pigs offer a  unique opportunity to study M.  M.  ~FRANK, J.  MAY, T.  GAITHER, AND  L.  ELLM.AN  183 
alternate  methods  of  activation  of  complement.  Several  studies  of in  vitro 
complement function have suggested that there may be alternate pathways of 
activation for the components of complement which act late in the complement 
sequence. Gewurz et al. showed that incubation of fresh guinea pig serum with 
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FIG. 4.  Fixation of complement components by antigen-antibody  complexes formed at 
equivalence. Comparison of pattern  of component fixation in  normal  guinea pig  serum, 
heterozygous C4-deficient, and C4-deficient serum. 
endotoxin  selectively  removed  the  late  components  of  complement  with 
minimal consumption of C1, C4, and C2 (20). Our studies with endotoxin and 
antigen-antibody  complexes confirm these findings.  Sandberg  et al.  reported 
that  guinea  pig  "rl  antibody,  classically  considered  to  be  a  noncomplement 
fixing immunolgobulin  (21),  when  assayed in the form of immune aggregates 
fixed late-acting complement components in a pattern similar to that seen with 184  COMPLEMENT  FUNCTION  IN  C4-DEPICIENT  GUINEA  PIGS 
endotoxin  (22).  Marcus et  al. found  that rabbit  anti-guinea pig  C2  antibody 
could prevent immune hemolysis but  was unable to inhibit  complement fixa- 
tion by endotoxin  (23).  These studies all suggest the existance of an alternate 
pathway, but suffer from the defect that it is impossible to rule out the presence 
of  antibodies which utilize minute amounts of C1,  C4,  and  C2 with extreme 
efficiency and activate the late components by the normal pathway. Studies of 
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FIe. 5. Fixation of complement components by E. coli endotoxin. Comparison of pattern 
of component fixation in normal guinea pig serum, heterozygous C4-deficient, and C4-deficient 
serum. 
immunoglobulin  function  have  suggested  that  different  classes  of  antibody 
utilize complement components with different efficiencies (24,  25).  Our studies 
indicate that endotoxin and antigen-antibody complexes are able to utilize the 
late components of complement in the sera of C4-deficient guinea pigs. There- 
fore,  an  alternate  pathway for  the  activation  of  the  late  components  must 
exist. In experiments to be reported in detail elsewhere, in vitro polymorpho- 
nuclear neutrophilic chemotactic factor generation in C4-deficient sera, requir- 
ing  activation  of late-acting  complement  components,  was  also  found  to  be 
normal:  ~ These results  also  indicate  operation  of  a  C4  bypass mechanism in 
2 Clark, R., H. Kimball, L. Ellman, and M. M. Frank. Unpublished observations. M.  M.  FRANK,  J.  MAY,  T.  GAITHER,  AND  L.  ELLMAN  185 
these sera. The demonstration of this bypass mechanism in vitro is in complete 
agreement with the in vivo demonstration of normal complement-dependent 
inflammatory responses in C4-deficient animals. 
Titers  of  C1  and  C2  may  also  be  decreased in  C4-deficient guinea  pigs. 
Although levels of C2 in the deficient animals are within the normal range of 
our laboratory of pooled, commercially available, Hartley strain sera, they are 
about one-half those of either their heterozygous littermates or normals of the 
same strain. We do not know whether this represents decreased synthesis of C2, 
reflecting a feedback control of C2 synthesis, or in increased catabolism. 
The C1  titer is not uniform in the group of C4-deficient animals. Three of 
eight animals tested had a normal C1 titer; the remaining five animals had titers 
of C1 which were 10-20% of normal. The titers were not low because of a gross 
defect in  activation of  C1  (Fig.  3)  and  the explanation for this variation is 
unknown. 
We have attempted to establish whether these complement-deficient animals 
might have the same defect as those reported by Moore in 1919 (14)  and sub- 
sequently described in detail by Hyde (19, 26). This earlier strain was thought 
to have a  deficiency of the  "classical" third  component of complement, but 
since C4 was not discovered until 1926 (27), sera from the earlier strain were 
not tested for the presence of C4 activity. This earlier strain has subsequently 
been lost, and since the origin of the NIH multipurpose strain is unknown, it 
was of interest to determine whether the C4-deficient guinea pigs have the same 
defect as the earlier strain. In both cases the complement component missing 
from the serum was heat stable. Yeast (zymosan)-treated serum, now known 
to be specifically depleted of C3,  was unable to restore the serum hemolytic 
activity  in  the  earlier  described  strain.  In  contrast,  the  serum  hemolytic 
activity of the C4-deficient strain was restored with zymosan-treated normal 
guinea  pig  serum.  Therefore,  C4-deficient  guinea  pigs  appear  to  be  a  new 
strain  of animals  unrelated to those discovered in  1919.  These animals offer 
unique  opportunities  for  studies  of  complement  function  and  pathways  of 
complement activation. 
SUMMARY 
In vitro studies were performed utilizing sera from a  strain of guinea pigs 
with  a  total  absence  of  hemolytically active  C4.  Previous  studies  in  these 
animals  have  demonstrated  normal  complement-dependent  inflammatory 
reactions,  suggesting that  they are able to bypass  their deficiency of C4.  In 
vitro studies with C4-deficient serum also indicate normal activation of late- 
acting C  components. Thus,  endotoxin was capable of fixing normal amounts 
of the late components of complement (C3-9)  in these sera,  but did not fix 
C1 and C2. Antigen-antibody complexes fixed both early and late components 
of  complement,  although  components  beyond  C4  were  fixed less  efficiently 
than in normal sera.  Therefore, both in vivo and in vitro evidence indicates 186  COMPLEMENT  FUNCTION  IN  C4-DEFICIENT  GUINEA  PIGS 
that  the C4-deficient guinea pigs possess an alternate  pathway for activation 
of late-acting complement components. 
Antigenic  analysis  of C4-deficient  serum  utilizing  both guinea  pig  anti-C4 
antibody and rabbit anti-C4 antibody suggests an absolute deficiency of C4-1ike 
molecules.  Sara from animals  with  C4-deficiency were found to have one-half 
the  normal  level  of  C2.  Sara  from five  of  eight  animals  tested  had  10-20% 
normal  C1  activity.  C3-9  assayed  as  a  complex  was normal. 
The authors wish to thank Dr. Ira Green for advice and help with the manuscript. 
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